Reasons to
on Hubb
Unified Worldwide Network
in Your Language
Unlimited Ads for FREE
First Page on Search Engines
under HUBB for FREE
Choose Your Own Keywords
for FREE
Multiple Service Apps for FREE
No Commission or Hidden Fees
Direct Contact with Customers
without Agents
Ability to Have Your Own Website
under HUBB for FREE
Expand Your Business
Overseas for FREE
Register now

Servier pharmaceutical Co.

Promote 2 views
Service category: Trading Companies


Servier is an international pharmaceutical company managed by a non-profit fund, headquartered in Suresnes, France.

Servier is widely distributed worldwide, with international operations in 149 countries and a total of 22,000 employees worldwide.

As a completely independent company, the group invests an average of 25% of its operating income into drug research and development (excluding generic drugs) every year, and uses all profits for corporate development.

The continuous pursuit of innovation in five outstanding areas of cardiovascular disease, immune inflammatory disease, neurodegenerative disease, cancer and diabetes is the driving force for Servier's growth.

In addition to drug development, Servier also provides eHealth solutions.

In 1979, Servier became one of the first multinational companies to enter China.

Commitment to care for more than 40 years, Servier China currently covers 29 provinces, cities and regions, and has become the largest professional team of the group;

The six regional offices are located in Beijing, Jinan, Shanghai, Hangzhou, Wuhan and Guangzhou.

Servier China has maintained its leading position in the industry in the management of cardiovascular diseases and diabetes patients;

And will actively expand business in the oncology field. Provide treatment drugs and programs for 3 million patients every day.

As Servier’s only industrial production base in Asia, Servier’s Tianjin factory has been committed to

Provide our high-quality innovative drugs to patients in China and some Asian countries, and support local clinical research.

Focusing on the five major areas of cardiovascular, diabetes, immune inflammation, tumor and neurodegenerative diseases,

Servier International Medical Research Center (ICTR) has carried out 52 international and domestic clinical research projects in more than 400 hospitals in Greater China.

Nearly 13,000 Chinese patients were enrolled.

Promotions and offers

Contact person: Servier pharmaceutical Co.
All the services you need on one platform
Ordering Services Online
All the services you need on one platform
Ordering Services Online

Avalible Services

Coming soon

Show all
Login on Hubb
Reset password